Department of Endocrine and Digestive Surgery, Hôpital Saint-Louis, Paris, France.
J Am Coll Surg. 2010 Apr;210(4):456-62. doi: 10.1016/j.jamcollsurg.2009.12.017.
The aim of this study was to identify the specific preoperative characteristics of patients with parathyroid microadenoma and to report their outcomes after surgical treatment.
Parathyroid microadenomas (weight < 100 mg) were identified in 62 (6%) of the 1,012 patients operated on for a parathyroid adenoma between 1995 and 2004. Presentation and outcomes after surgery were compared with those of 124 patients operated on consecutively for parathyroid adenoma (>100 mg) during the last year of the study. All patients underwent bilateral surgical exploration of the neck. Success was defined as resection of a pathologic gland combined with normocalcemia at 6 months after operation. Logistic regression was used to test the relationship between groups and potential predictive factors of microadenoma.
There were 57 women (92%) and the median age was 57 years (range 29 to 77 years). Median preoperative calcemia and parathyroid hormone (PTH) serum levels were 2.64 mmol/L (range 2.31 to 3 mmol/L) and 79 pg/mL (range 30 to 189 pg/mL), respectively. There was no difference in the clinical presentation between patients with microadenoma and adenoma. Preoperative calcium (p < 0.001) and PTH serum levels (p = 0.014) were significantly higher in patients with adenoma. Calcium and PTH serum levels lower than 2.6 mmol/L and 60 pg/mL, respectively, predicted the presence of microadenoma with respective specificities of 0.89 and 0.87. Success rates were similar in the microadenoma and adenoma groups (92% vs 98%; p = 0.11).
Mild preoperative elevations of calcium or PTH serum levels should warn about the risk of microadenoma. In this setting, intraoperative difficulties should be expected in identifying the pathologic gland, and bilateral neck exploration should be the preferred surgical approach.
本研究旨在确定甲状旁腺微小腺瘤患者的具体术前特征,并报告其手术治疗后的结果。
在 1995 年至 2004 年间,对 1012 例甲状旁腺腺瘤患者进行了手术治疗,其中 62 例(6%)被诊断为甲状旁腺微小腺瘤(重量<100 毫克)。将手术治疗后的表现和结果与同年最后一年连续接受甲状旁腺腺瘤(>100 毫克)手术治疗的 124 例患者进行比较。所有患者均接受双侧颈部手术探查。成功定义为切除病理腺体,术后 6 个月血钙正常。采用逻辑回归检验组间关系及微小腺瘤的潜在预测因素。
患者 57 例(92%)为女性,中位年龄为 57 岁(范围 29 至 77 岁)。中位术前血钙和甲状旁腺激素(PTH)血清水平分别为 2.64mmol/L(范围 2.31 至 3mmol/L)和 79pg/mL(范围 30 至 189pg/mL)。微小腺瘤和腺瘤患者的临床表现无差异。腺瘤患者的术前血钙(p<0.001)和 PTH 血清水平(p=0.014)显著升高。血清钙和 PTH 水平分别低于 2.6mmol/L 和 60pg/mL 时,预测微小腺瘤的特异性分别为 0.89 和 0.87。微小腺瘤组和腺瘤组的成功率相似(92%对 98%;p=0.11)。
术前血钙或 PTH 血清水平轻度升高应提示存在微小腺瘤的风险。在这种情况下,术中识别病理腺体可能会遇到困难,双侧颈部探查应是首选的手术方法。